MXPA03004209A - Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans. - Google Patents

Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans.

Info

Publication number
MXPA03004209A
MXPA03004209A MXPA03004209A MXPA03004209A MXPA03004209A MX PA03004209 A MXPA03004209 A MX PA03004209A MX PA03004209 A MXPA03004209 A MX PA03004209A MX PA03004209 A MXPA03004209 A MX PA03004209A MX PA03004209 A MXPA03004209 A MX PA03004209A
Authority
MX
Mexico
Prior art keywords
cell migration
inhibitor
langerhans cell
pharmaceutical
cosmetic composition
Prior art date
Application number
MXPA03004209A
Other languages
English (en)
Inventor
Philippe Msika
Original Assignee
Pharmascience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmascience Lab filed Critical Pharmascience Lab
Publication of MXPA03004209A publication Critical patent/MXPA03004209A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La invencion se refiere a una composicion farmaceutica o cosmetica, caracterizada porque comprende por lo menos un compuesto para inhibir la migracion de celulas de Langerhans, dicho compuesto activo siendo seleccionado del grupo que consta de compuestos inhibidores de proteina cinasa C (PKC), compuestos inhibidores de metaloproteasas de matriz (MMP), y combinaciones de los mismos, y por lo menos un vehiculo farmaceutica o cosmeticamente aceptable; dicha composicion permite inhibir considerablemente la migracion de celulas de Langerhans inducida por la presencia de un agente alergenico.
MXPA03004209A 2000-11-14 2001-11-14 Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans. MXPA03004209A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014607A FR2823117A1 (fr) 2000-11-14 2000-11-14 Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
PCT/FR2001/003568 WO2002040004A1 (fr) 2000-11-14 2001-11-14 Composition pharmaceutique ou cosmetique et utilisation d'un inhibiteur de pkc avec un inhibiteur de mmp pour inhiber la migration des cellules de langerhans

Publications (1)

Publication Number Publication Date
MXPA03004209A true MXPA03004209A (es) 2004-03-26

Family

ID=8856405

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004209A MXPA03004209A (es) 2000-11-14 2001-11-14 Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans.

Country Status (12)

Country Link
US (3) US7511010B2 (es)
EP (1) EP1343486B1 (es)
JP (1) JP4184787B2 (es)
KR (1) KR20040030457A (es)
CN (1) CN100409841C (es)
AU (1) AU2002218371A1 (es)
CA (1) CA2428707A1 (es)
DE (1) DE60123113T2 (es)
ES (1) ES2271118T3 (es)
FR (1) FR2823117A1 (es)
MX (1) MXPA03004209A (es)
WO (1) WO2002040004A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
ITRM20010688A1 (it) 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
FR2834213B1 (fr) * 2001-12-27 2004-06-04 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
EP1676572A1 (en) * 2003-09-26 2006-07-05 Kirin Beer Kabushiki Kaisha Remedy for autoimmune diseases
JP2005281257A (ja) * 2004-03-30 2005-10-13 Snow Brand Milk Prod Co Ltd 美肌剤
GB0513431D0 (en) * 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
CA2620022A1 (en) * 2005-08-31 2007-03-08 Serentis Limited Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus
KR100849019B1 (ko) * 2006-06-28 2008-07-29 (주)더페이스샵코리아 화이트 루핀 추출물을 함유하는 화장료 조성물
WO2011133555A2 (en) * 2010-04-20 2011-10-27 The Research Foundation Of State University Of New York Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration
JP2013071918A (ja) * 2011-09-28 2013-04-22 Shiseido Co Ltd フィラグリン産生促進剤
AU2013204785C1 (en) 2012-07-09 2019-09-05 Fin Control Systems Pty. Limited Fin Plug for Water Craft
AU2013204755A1 (en) 2012-11-14 2014-05-29 Fin Control Systems Pty. Limited A Fin Plug for a Water Craft
US10251897B2 (en) 2014-01-17 2019-04-09 Nishizaki Bioinformation Research Institute GLUT4 endocytosis inhibitor
EP3807244B1 (en) * 2018-06-15 2024-03-13 Carbocode S.A. Sphingosine/sphingoid base production
JP2022537336A (ja) * 2019-06-18 2022-08-25 ドイチェス クレブスフォルシュングスツェントルム 制御性ｃｄ４＋ ｔ細胞を生成するためのスフィンゴ脂質
CN111388483B (zh) * 2020-04-28 2022-09-09 上海市中医医院 具有协同作用治疗抗***感染的药物组合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891906A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Polyacetate-derived phorboids having anti-inflammatory and other uses
CZ188394A3 (en) * 1992-02-07 1996-02-14 Albert M Kligman Pharmaceutical preparation for the control of inflammatory dermatose cleaning and the use of corticosteroidal matter in combination with a retoidal matter for preparing such preparations
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
EP0642353A1 (en) 1992-05-14 1995-03-15 Oncologix, Inc. Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
US5981491A (en) * 1995-05-10 1999-11-09 Darwin Discovery Limited Peptidyl compounds and their therapeutic use
US6040152A (en) * 1996-12-31 2000-03-21 National Jewish Medical And Research Center Method and assay for regulation of T cell proliferation
JP2002515898A (ja) * 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
AU6843298A (en) 1997-03-28 1998-10-22 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
JP4247846B2 (ja) * 1997-07-03 2009-04-02 デュピュイ・スパイン・インコーポレーテッド 架橋ポリサッカリド薬物キャリア
US6218113B1 (en) 1998-02-24 2001-04-17 Incyte Genomics, Inc. Human protein kinase C inhibitor
EP1101496A4 (en) * 1998-07-17 2001-12-12 Fuji Yakuhin Kogyo Kk THERAPEUTIC AGENTS FOR ALLERGY DISEASES
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
FR2826011B1 (fr) * 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique

Also Published As

Publication number Publication date
EP1343486A1 (fr) 2003-09-17
DE60123113D1 (de) 2006-10-26
CN100409841C (zh) 2008-08-13
US20110009333A1 (en) 2011-01-13
FR2823117A1 (fr) 2002-10-11
JP2004513919A (ja) 2004-05-13
CN1486179A (zh) 2004-03-31
KR20040030457A (ko) 2004-04-09
CA2428707A1 (fr) 2002-05-23
AU2002218371A1 (en) 2002-05-27
WO2002040004A1 (fr) 2002-05-23
JP4184787B2 (ja) 2008-11-19
US20040067910A1 (en) 2004-04-08
EP1343486B1 (fr) 2006-09-13
ES2271118T3 (es) 2007-04-16
US20080221017A1 (en) 2008-09-11
DE60123113T2 (de) 2007-04-05
US7511010B2 (en) 2009-03-31

Similar Documents

Publication Publication Date Title
MXPA03004209A (es) Composicion farmaceutica o cosmetica y uso de un inhbidor de proteina cinasa c con un inhibidor de metaloproteasas de la matriz para inhibir la migracion de celulas de langerhans.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
HUP0200355A3 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
CO5271710A1 (es) Combinanciones de un inhibidor de cinasa de tirosina receptora con un compuesto organico capaz de enlazarse con glicorpoteina acido-a
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
EA200200207A1 (ru) Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы
IS2369B (is) Ný blanda 5-HT4 gerandefna eða mótlyfja til inntöku um munn
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES2171018T3 (es) Uso de agentes inmunomoduladores.
TR200101337T2 (tr) Değiştirilmiş salımlı ensülin sensitizörü için farmasötik terkip ve kullanımı.
BR0113148A (pt) Composições de 2-piridinamina e métodos relacionados
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
IL134930A0 (en) Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases
IL143299A0 (en) Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparation
WO2002057248A3 (en) Inhibitors of cruzipain and other cysteine proteases
AU5063700A (en) S-nitroso- and s-nitro-n-acyl-l-cysteine-ester-derivatives as pharmacological substances and medicaments containing said compounds
SV2004000087A (es) Amidas de acidos fenilciclohexanocarboxilicos sustituidos ref. lea 33469-sv
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
IT1306187B1 (it) Metodo per l'eradicazione selettiva di cellule tumorali aventi lafunzione di p53 inattiva.